Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stephen M. Strittmatter, Yale University
ClinicalTrials.gov Identifier:
NCT01864655
First received: May 8, 2013
Last updated: June 12, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: No date given
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):